Table 2.
Effect of Atg5 siRNA on the CI of PI103 and Ku-0063794 in GC cells grown in LG and HG conditions
| Cell line | Glucose | CI at fu 0.5 | |
|---|---|---|---|
| Control siRNA | Atg5 siRNA | ||
| AGS | High | 0.98 ± 0.09 | 0.32 ± 0.01* |
| Low | 0.08 ± 0.003 | 3.8 ± 0.9* | |
| HGC27 | High | 1.1 ± 0.06 | 0.14 ± 0.06* |
| Low | 0.04 ± 0.002 | 4.6 ± 0.18* | |
| MKN45 | High | 0.98 ± 0.02 | 1.1 ± 0.05 |
| Low | 0.89 ± 0.04 | 0.93 ± 0.02 | |
| NUGC4 | High | 1.1 ± 0.28 | 0.99 ± 0.08 |
| Low | 1.4 ± 0.82 | 1.3 ± 0.11 | |
The CI values of PI103 and Ku-0063794 (in the presence of the other drug at fixed, non-growth inhibitory concentrations of one-fifth IC50) at fu 0.5 in the presence or absence of Atg5 siRNA are displayed. Additivity = 1, antagonism > 1, synergy < 1.
P < 0.05 for differences from unity for CI values.